Reaction
Squamous Cell Carcinoma Of Lung reporting signals
As of the last recalculation, Squamous Cell Carcinoma Of Lung appears in 759 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is BARICITINIB (PRR 46.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Baricitinib | 16 | 46.5 | 46.5 |
| Nintedanib | 16 | 14.3 | 14.3 |
| Pemetrexed | 11 | 14.3 | 14.3 |
| Carboplatin | 61 | 14.2 | 14.2 |
| Gefitinib | 4 | 12.2 | 12.2 |
| Paclitaxel (Aibumin-Bound) | 35 | 12.2 | 12.2 |
| Paclitaxel | 41 | 11.9 | 11.9 |
| Vemurafenib | 4 | 9.2 | 9.2 |